December 13, 2024 23:10 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Bengaluru techie suicide: Karnataka Police issues summons to wife Nikita, her family members | French President Macron appoints centrist leader Francois Bayrou as new Prime Minister | Congress always prioritised personal interest over Constitution: Rajnath Singh | Jaishankar calls attack on Hindus in Bangladesh 'a source of concern' | Allu Arjun arrested over woman's death in stampede during Pushpa 2 premiere show | RBI receives bomb threat in Russian language, case filed | UP teenager kills mother, lives with body for 5 days | At least six people including a child killed in Tamil Nadu hospital fire | Amid Atul Subhash row, SC says mere harassment is not enough to prove abetment to suicide | India's D Gukesh becomes youngest ever world champion in chess
Omicron
UNI

India registers 7,145 new COVID-19 cases in past 24 hours amid Omicron spread scare

| @indiablooms | Dec 18, 2021, at 03:11 pm

New Delhi: India, a nation which is witnessing a spike in Omicron cases, registered 7,145 new COVID-19 cases in the past 24 hours, as per data released by the Ministry of Health on Saturday.

During the same period, 391 people died due to the disease.

India's Active caseload currently stands at 84,565, lowest in 569 days.

Active cases account for less than 1 percent of total cases.

It currently stands at 0.24 percent.

8,706 recoveries were recovered in the last 24 hours.

Recovery Rate currently stands at 98.38 percent.

The World Health Organization (WHO) on Friday announced that  it has granted emergency approval to the India-manufactured COVID-19 vaccine Covovax.

"Today, the World Health Organization issued and emergency use listing (EUL) for NVX-CoV2373, expanding the basket of WHO-validated vaccines against the SARS-CoV-2 virus," the WHO said in a statement.

The vaccine, named CovovaxTM, is produced by the Serum Institute of India (SII) under license from Novavax and is part of the COVAX facility portfolio.

The vaccine approval is "a much-needed boost to ongoing efforts to vaccinate more people in lower-income countries."

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.